MedTrace Logo

Childhood Uveitis Initial Management and One-year Outcomes

NCT02490254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-04-12

No results posted yet for this study

Summary

The investigators wish to establish a robust estimate of the incidence of inflammation inside the eye (uveitis) in children age 0-16 years in the UK, which hospitals children present to, where they are referred to, which treatment they receive during the first year after diagnosis, and how well they can see at the end of the first year.

Conditions

  • Uveitis

Interventions

OTHER

Surveillance card

Sponsors & Collaborators

  • Moorfields Eye Hospital NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Annegret Dahlmann-Noor, Dr Med PhD · Moorfields Eye Hospital NHS Foundation Trust

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2017-03-31
Completion
2017-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490254 on ClinicalTrials.gov